EE200100020A - Pharmaceutical Use of NAB1 and NAB2 - Google Patents

Pharmaceutical Use of NAB1 and NAB2

Info

Publication number
EE200100020A
EE200100020A EEP200100020A EEP200100020A EE200100020A EE 200100020 A EE200100020 A EE 200100020A EE P200100020 A EEP200100020 A EE P200100020A EE P200100020 A EEP200100020 A EE P200100020A EE 200100020 A EE200100020 A EE 200100020A
Authority
EE
Estonia
Prior art keywords
nab1
nab2
pharmaceutical use
pharmaceutical
Prior art date
Application number
EEP200100020A
Other languages
Estonian (et)
Inventor
Braddock Martin
Jeffrey Campbell Callum
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9814989.1A external-priority patent/GB9814989D0/en
Priority claimed from GBGB9819826.0A external-priority patent/GB9819826D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of EE200100020A publication Critical patent/EE200100020A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP200100020A 1998-07-11 1999-07-09 Pharmaceutical Use of NAB1 and NAB2 EE200100020A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9814989.1A GB9814989D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819826.0A GB9819826D0 (en) 1998-09-12 1998-09-12 Gene therapy method
PCT/GB1999/002199 WO2000003014A1 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2

Publications (1)

Publication Number Publication Date
EE200100020A true EE200100020A (en) 2002-06-17

Family

ID=26314007

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100020A EE200100020A (en) 1998-07-11 1999-07-09 Pharmaceutical Use of NAB1 and NAB2

Country Status (22)

Country Link
EP (1) EP1097200A1 (en)
JP (1) JP2002520020A (en)
KR (1) KR20010071832A (en)
CN (1) CN1317045A (en)
AP (1) AP2001002038A0 (en)
AU (1) AU763713B2 (en)
BR (1) BR9912018A (en)
CA (1) CA2336805A1 (en)
EA (1) EA200100028A1 (en)
EE (1) EE200100020A (en)
HR (1) HRP20010025A2 (en)
HU (1) HUP0102835A3 (en)
ID (1) ID27742A (en)
IL (1) IL140533A0 (en)
IS (1) IS5788A (en)
NO (1) NO20010166L (en)
NZ (1) NZ509174A (en)
PL (1) PL345507A1 (en)
SK (1) SK382001A3 (en)
TR (1) TR200100622T2 (en)
WO (1) WO2000003014A1 (en)
YU (1) YU1901A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
AU2001291019A1 (en) 2000-09-15 2002-03-26 Genvec, Inc. Method of modulating neovascularization
WO2004083435A1 (en) * 2003-03-17 2004-09-30 Julius-Maximilians-Uni Versität Würzburg Nab proteins and their use in diagnostic and therapeutic applications in heart disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5697901A (en) * 1989-12-14 1997-12-16 Elof Eriksson Gene delivery by microneedle injection

Also Published As

Publication number Publication date
NO20010166D0 (en) 2001-01-10
TR200100622T2 (en) 2001-10-22
AU763713B2 (en) 2003-07-31
ID27742A (en) 2001-04-26
EP1097200A1 (en) 2001-05-09
AU4791499A (en) 2000-02-01
NZ509174A (en) 2003-08-29
YU1901A (en) 2005-06-10
BR9912018A (en) 2006-01-31
KR20010071832A (en) 2001-07-31
EA200100028A1 (en) 2001-08-27
CN1317045A (en) 2001-10-10
SK382001A3 (en) 2001-09-11
HUP0102835A3 (en) 2003-09-29
CA2336805A1 (en) 2000-01-20
NO20010166L (en) 2001-03-06
JP2002520020A (en) 2002-07-09
HRP20010025A2 (en) 2001-12-31
HUP0102835A2 (en) 2001-11-28
IS5788A (en) 2000-12-22
AP2001002038A0 (en) 2001-03-31
PL345507A1 (en) 2001-12-17
WO2000003014A1 (en) 2000-01-20
IL140533A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
EE04144B1 (en) A pharmaceutical composition and its use
BR9500784A (en) Compound and pharmaceutical formulation
BR9504060A (en) Compound and pharmaceutical formulation
PT1066027E (en) PHARMACEUTICAL COMPOSITION OF TOPIRAMATO
PT892640E (en) PHARMACEUTICAL COMPOUNDS OF MYCOFENOLATE
PT1119557E (en) DERIVATIVES OF INDENE- NAFTO- AND BENZOCYCLOHEPTA-DI-HYDROTIAZOLE ITS PREPARATION AND ITS USE AS ANORECTICAL MEDICINES
DE69925262D1 (en) PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISEASES
EE200100258A (en) Anthranilic acid amides and their use as medicaments
FI972292A0 (en) Administration of diabetes
FI953479A0 (en) 1-Arylpyrimidine derivatives and their pharmaceutical use
BR9506119A (en) Pharmaceutical composition and unit pharmaceutical dosage form
PT934057E (en) MEDICAL FORMULATIONS OF AEROSOLS WITH FORMOTEROL
PT1006110E (en) DERIVATIVES OF ACIL-PIPERAZINYL-PYRIMIDINES ITS PREPARATION AND APPLICATION AS MEDICINES
LV12624B (en) Thienylazolylalkosietanamines and their application to the drug legusana
FI965204A0 (en) Medicinal use of bromelain
ATE212225T1 (en) INJECTABLE MEDICINAL PREPARATION CONSISTING OF PARACETAMOL
ATA191697A (en) MEDICINES FOR PROMOTING Wound Healing
EE200100051A (en) Use of (+) - norcisapride or a pharmaceutically acceptable salt thereof substantially free of the corresponding (-) - stereoisomer and pharmaceutical composition
BR9907100B1 (en) pentasaccharides, a pharmaceutical composition comprising them and use of said pentasaccharides
FI964619A (en) Dosage of antiepileptic drugs on the skin
PT1194038E (en) COMPOSITION OF BREACH OF THE REST AND ITS USE
EE9900578A (en) Pharmaceutical compositions of tisoxanide and nitazoxanide
EE200100020A (en) Pharmaceutical Use of NAB1 and NAB2
FI963263A (en) Medical use of bromelain
BR9703132A (en) Medical timer